Empowering Medical Aesthetic Clinics, Practitioners, and Patients 10 Botox® Techniques and Tips for Awesome Results
Last updated: September 2026
Becoming a skilled Botox® injector doesn’t happen overnight. It takes careful training, in-depth knowledge of facial anatomy and the injection sites that sit on top of it, and a lot of practice. In this article we share our top ten Botox® techniques and tips for becoming a confident cosmetic injector — and we anchor each one to what the current product labeling actually says.
As with any new procedure, the more often you perform it the more comfortable you become. That is why we recommend treating friends and family before officially adding Botox® injections to your practice’s roster, so you can learn to see even the very subtle differences between your patients’ facial structures.
Two things have changed since this guide was first published, and both belong in your technique. There are now six FDA-approved botulinum toxin products for aesthetic use in the United States rather than three, and the BOTOX® Cosmetic label has grown a fourth aesthetic indication, with a fifth under FDA review. Both are covered below.
Key Takeaways
- Know the on-label numbers before you deviate from them. The labeled glabellar dose is 20 Units total — 4 Units into each of 5 sites. Higher totals are common in practice and are off-label.
- Two separate orbital margins, not one. Place lateral corrugator injections at least 1 cm above the bony supraorbital ridge, and never inject closer than 1 cm above the central eyebrow.
- Units are never interchangeable between products. BOTOX® Units cannot be compared to or converted into the Units of any other botulinum toxin. This is the real reason to triple-check every label.
- Reconstitute with preservative-free saline, use within 24 hours, store at 2–8 °C. Write the reconstitution time on the vial.
- Never tell a patient to stop a prescribed anticoagulant. Elective over-the-counter agents are a different conversation from prescribed therapy.
- Six FDA-approved toxins, four approved BOTOX® Cosmetic indications. Platysma bands joined the label in 2024; the masseter sBLA was accepted by the FDA in August 2026.
1. Understand Facial Anatomy
It is vital that before you treat your first patient you are absolutely sure you understand facial anatomy. You need to know not just the proper name of each muscle, but its location, its function, its depth, and which muscles oppose it. You also need to know where the vessels run.
Some healthcare providers find it helpful to keep a facial injection chart on hand. Besides making review quick, a chart is a useful tool for explaining the details of a Botox® injection to your patients.
The anatomy that matters most for safety is the anatomy you cannot see. In the glabellar complex, the levator palpebrae superioris sits immediately behind the corrugator; diffusion of even a small amount of product into it is the mechanism behind eyelid ptosis. In the lateral canthal area, the zygomaticus major sits just below the crow’s-feet field, and treating too low produces a lip or smile asymmetry that no amount of touch-up will fix before the toxin wears off.
2. Remember Your Botox® Training
There is a reason “go back to the basics” is repeated so often: it works. If you start to feel overwhelmed treating patients, think back to the training you received and mentally walk yourself through the different Botox® techniques you learned while earning your certification.
Pro tip Do this out loud, as part of the conversation you have with your patient about the procedure. Talk them through every step both before and while you are administering it. The repetition reinforces your own sequence and it puts your patients at ease at the same time.
3. Triple Check Your Botox® Labels
Allergan Aesthetics — an AbbVie company since 2020 — is the only manufacturer of BOTOX® and BOTOX® Cosmetic, but there are now six FDA-approved botulinum toxin products for aesthetic use in the United States, each from a different manufacturer. Each one has its own reconstitution instructions and its own diluent volumes, and each one carries a separate potency assay.
That last point is the one that matters clinically, and it is the reason this seemingly common-sense tip is on the list. It is entirely possible that your practice will hold stock from more than one manufacturer at the same time. Always verify which product you are holding before you begin:
- Check during the drug’s preparation.
- Check when you remove it from storage.
- Check again immediately before administering the injections.
From the BOTOX® Cosmetic label “Units of biological activity of BOTOX Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products.”
There is no conversion ratio. A dose written in one product’s Units is meaningless in another’s. Chart the product name alongside the dose every single time, and never carry a dose forward from a previous visit without confirming which product was used.
The Six FDA-Approved Aesthetic Neurotoxins
When this guide was first written, most injectors were choosing between three products. There are now six, and a patient who says “I had Botox® last time” may well mean something else entirely.
| Product | Generic name | US aesthetic approval |
|---|
| BOTOX® Cosmetic | onabotulinumtoxinA | 2002 |
| Dysport® | abobotulinumtoxinA | 2009 |
| Xeomin® | incobotulinumtoxinA | 2011 |
| Jeuveau® | prabotulinumtoxinA-xvfs | 2019 |
| Daxxify® | daxibotulinumtoxinA-lanm | 2022 |
| Letybo® | letibotulinumtoxinA-wlbg | 2024 |
All six carry an aesthetic indication for glabellar lines. Indications beyond the glabella differ by product — check the label for the product in your hand, not the one you know best.
4. Mind Your Details
Double-check even tiny details. A few habits from our Botox® training program:
- Make sure the alcohol you used to wipe the vial stopper has completely evaporated before you pierce it. Otherwise some of the alcohol can be drawn into the vial.
- Have everything you need ready before the patient arrives — needles, gauze, diluent, and a marking pen if you use one. A small clean tray keeps the sequence tidy and repeatable.
- Always take photos. Patients often don’t pay attention to what they looked like before they came in, and may have forgotten the small depression or the brow asymmetry they have had since birth. A consistent pre-procedure photography protocol — same lighting, same distance, same expressions, both at rest and in full animation — is the single cheapest piece of medico-legal protection in an aesthetic practice.
- Write the reconstitution date and time on every vial the moment you reconstitute it, not later.
Handling, Reconstitution and Storage
Technique starts before the needle goes in. The label is specific on all three points, and getting any of them wrong quietly costs you potency — which the patient experiences as “it didn’t work on me.”
- Diluent: reconstitute with sterile, preservative-free 0.9% sodium chloride injection only. Inject the diluent gently down the side of the vial — the product is a protein and brisk agitation can denature it. Discard the vial if the vacuum does not pull the diluent in.
- Needle change: remove the needle used for reconstitution and attach a fresh 30–33 gauge needle for injection.
- Time: administer within 24 hours of reconstitution.
- Temperature: store the reconstituted vial in a refrigerator at 2–8 °C during that window.
5. Botox® Needle Choice Is Important
The needle you choose plays a large role in managing patient pain during a Botox® injection. The label instructs you to attach a 30–33 gauge needle once the product is reconstituted. In practice most injectors work at the finer end of that range — a 31 or 32 gauge insulin-style syringe — because the smaller bore means less discomfort on entry and better control of a small volume.
Use a short, single-use needle, and change it between patients without exception. These are available through any standard medical supplier. Bear in mind that a fine needle dulls quickly; if you are treating multiple areas in one session, a fresh needle partway through is more comfortable for the patient than a blunted one.
6. Dosage Matters
Botox® is not a one-size-fits-all treatment. Every patient is different, and it matters that you dose for the individual patient and not just for the procedure. Male patients generally have bulkier corrugator, procerus and frontalis muscles than female patients, and typically require higher doses for an equivalent effect.
Dose for the individual — but know the labeled number you are departing from, and document the departure. The chart below is the FDA-approved dosing for BOTOX® Cosmetic.
| Treatment area | On-label total dose | How it is distributed |
|---|
| Glabellar lines | 20 Units | 4 Units into each of 5 sites |
| Lateral canthal lines (crow’s feet) | 24 Units | 12 Units per side, across 6 sites total |
| Forehead lines | 40 Units | 20 Units forehead (4 Units × 5 sites) plus 20 Units glabellar — the forehead indication is approved only in combination with glabellar treatment |
| Platysma bands | 26, 31 or 36 Units | Selected by severity of platysma prominence |
| Masseter prominence | Not FDA approved | Off-label in the US; sBLA accepted by the FDA in August 2026 |
Doses above are for BOTOX® Cosmetic and do not transfer to any other product.
On off-label dosing You will see glabellar totals well above 20 Units recommended in the aesthetic literature and used routinely in male patients. That is a legitimate clinical decision within your scope — but it is off-label, it belongs in your informed consent, and it belongs in the chart. Knowing you are off-label is the difference between a considered clinical judgement and an accident.
7. Botox® Technique Tip: Watch the Eyes
When you are administering Botox® treatments for glabellar and lateral canthal lines — two of the most popular procedures — make sure your bevel is oriented up and aimed away from your patient’s eye.
The label gives two separate margins for the glabellar complex, and they are frequently collapsed into one rule of thumb. Both matter:
- Place lateral corrugator injections at least 1 cm above the bony supraorbital ridge.
- Do not inject closer than 1 cm above the central eyebrow.
Respecting both is what keeps product away from the levator palpebrae superioris. When it does reach that muscle, the result is eyelid ptosis after Botox® — and it is worth knowing that eyelid ptosis is the most commonly reported adverse reaction in the glabellar trials, not a rare freak event. It resolves as the toxin wears off, but that is weeks of an unhappy patient, so the margins are worth more than the extra millimetre of correction.
8. Patients Only Remember the Pain
Injections are almost always going to be at least a little painful, even with a fine needle. To improve your patient’s comfort, numb the injection areas before you administer the procedure.
Because the injections are shallow, the simplest approach is ice — applied for a minute or so immediately before injecting. A topical anaesthetic is an option where a patient is particularly anxious or the field is large, but it requires enough dwell time to actually work, so build it into the appointment rather than applying it as you go. Vibration applied adjacent to the injection site is another low-cost option that works on the same gate-control principle as ice.
9. Only Hit Home Runs
Not everybody is a good candidate for Botox® treatment. Some patients are more prone to serious side effects than others, and for some the treatment simply won’t deliver what they are hoping for. Your patient’s history and current medical status are all important considerations before you agree to treat. Be thorough during your interviews and exams — declining to treat is a clinical skill, and it is one of the mistakes new injectors most often learn the hard way.
Contraindications and the Boxed Warning
BOTOX® Cosmetic carries a boxed warning for distant spread of toxin effect. The label states that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. Swallowing and breathing difficulties can be life-threatening, and although the reported cases have generally involved much larger therapeutic doses, patients treated cosmetically must know the symptoms and know to seek help immediately.
Do not treat — or treat with caution Absolute contraindications include known hypersensitivity to any botulinum toxin preparation or to any component of the formulation, and infection at the proposed injection site.
Treat with particular caution, and often not at all in a cosmetic setting, in patients with a peripheral motor neuropathic disease, amyotrophic lateral sclerosis, myasthenia gravis or Lambert-Eaton syndrome, all of which carry a heightened risk of clinically significant systemic effects. Aminoglycoside antibiotics and other agents that interfere with neuromuscular transmission can potentiate the effect of the toxin. Pregnancy and breastfeeding are reasons to defer an elective cosmetic treatment.
10. Project Positivity
Remember that while there are medical reasons to use Botox®, most patients interested in cosmetic injectables are insecure about some aspect of their appearance. It is important to be an empathetic listener and to pay close attention to your patient’s emotional responses to your advice.
If you are too gung-ho, your patient might worry that you agree with their insecurity. If you are too clinical, they are less likely to feel safe placing themselves in your hands. You learned a lot about bedside manner in your clinical training; this is a good moment to revisit it.
This is what your patients will remember more than anything else. It is what they communicate when they review your practice or decide whether to recommend you to friends and family.
It is natural to feel a little out of your depth as you begin performing these procedures on real patients. Use these tips as a guide as you gain experience and grow your practice — and make sure every patient leaves understanding the pre-care and post-care instructions below.
What’s New on the Label: Platysma Now, Masseter Next
Two developments are worth knowing before your next consultation, because patients are already asking about both.
Platysma prominence was added to the BOTOX® Cosmetic label in 2024, making it the fourth approved aesthetic indication alongside glabellar, lateral canthal and forehead lines. On-label dosing is 26, 31 or 36 Units, selected by severity. If you have been treating platysmal banding off-label, this is now a labeled indication with labeled dosing behind it.
Masseter prominence is not approved yet. Allergan Aesthetics announced on 4 August 2026 that the FDA had accepted a supplemental Biologics License Application for BOTOX® Cosmetic in masseter muscle prominence, which would become its fifth aesthetic indication. Until a decision is issued, masseter Botox® for jawline slimming remains an off-label use in the United States and should be consented and charted as such.
Botox® Pre-Care Instructions
When taking on a patient for treatment there are specific questions that need to be asked to avoid unwanted complications or adverse reactions.
Medical History
Take a complete medical history to determine whether Botox® is a suitable treatment. You need to know about medical illnesses, diseases and conditions, any previous surgeries or procedures, and specifically about the neuromuscular conditions listed above. Establish whether the patient is pregnant or breastfeeding.
Medications
Ask about prescription medication, over-the-counter medication, herbs, supplements and allergies. Two categories need to be handled differently, and conflating them is a genuine risk to the patient:
- Elective over-the-counter agents that increase bruising — aspirin taken without a medical indication, ibuprofen, naproxen, vitamin E, fish oil, ginseng and ginkgo biloba — may reasonably be paused for about a week beforehand to reduce bruising. Acetaminophen is the usual alternative for analgesia in that window.
- Prescribed anticoagulant or antiplatelet therapy — warfarin, a direct oral anticoagulant, clopidogrel, or aspirin prescribed for cardiac or cerebrovascular indications — must never be stopped on your instruction. That decision belongs to the prescribing physician. The bruising you are trying to prevent is cosmetic and temporary; the thrombotic event you could cause is neither. Treat the patient on their therapy, or defer the treatment.
Alcohol
Cutting down on alcohol in the days leading up to the procedure helps reduce bruising.
Expectations
With first-time Botox® patients, the IAPAM recommends a thorough examination of the face together with a full discussion of what the patient expects from treatment. This helps decide whether Botox® is the right course of action, since a neuromodulator addresses dynamic lines and can only do so much about static folds, volume loss or skin quality. Brief the patient on the procedure, on realistic timelines — onset over several days, peak effect at roughly two weeks, duration of about three to four months for most products — and on the side effects, so the result lands as expected rather than as a disappointment.
Region to Treat
Once Botox® is agreed as the right approach, decide which facial regions to treat. Ask patients what their definition of an ideal result is, because the patient and the practitioner sometimes disagree on it, and your treatment plan needs to align with theirs before a needle comes out.
Botox® Aftercare Treatment
After the injections, the IAPAM recommends the patient take certain precautions and follow these aftercare instructions. It is worth being honest with patients about which of these rest on firm evidence and which are conservative convention — they will find the conflicting advice online anyway, and the practitioner who explains the difference is the one they trust.
Facial Expressions
Exercising the treated muscles with natural facial expressions for the first hour is commonly advised, on the theory that active muscle uptake speeds onset. It is harmless and may modestly shorten the time to effect; it is not a requirement for the treatment to work.
Massage
Patients should avoid rubbing or massaging the treated areas for several hours after the procedure, so that product is not displaced into adjacent muscles. This one matters — it is the same mechanism behind brow and eyelid ptosis.
Painkillers
Analgesia should rarely be needed. Where a patient wants something for a post-treatment headache, acetaminophen is preferred over aspirin and ibuprofen in the first 24 hours, since those increase bruising. A patient on prescribed aspirin continues to take it as prescribed.
Ice and Bruising
Mild bruising can occur and may last a few days. Let patients know this is normal and can be managed with ice applied to the area. Arnica or vitamin K preparations are sometimes suggested; the evidence for them is weak, so present them as optional rather than necessary.
Facial Treatments
Chemical peels, microdermabrasion, laser and facial massage should be deferred for at least 24 hours, and many practitioners prefer to wait two weeks, so that manipulation of the treated area cannot displace product and so that any bruising is not compounded.
Physical Activity
Strenuous exercise is usually deferred for the rest of the day, and patients are asked not to lie flat or bend forward for about four hours. The rationale is displacement of product, not systemic spread — but patients should still know the boxed-warning symptoms and know to contact you or seek urgent care immediately if they develop difficulty swallowing, speaking or breathing, or generalised muscle weakness, at any point after treatment.
Alcohol
Alcohol is best avoided for the first 24 hours, as it increases bruising and swelling.
Practitioners who take the time to walk their patients through these before-and-after measures get better Botox® results and fewer anxious phone calls — and patients who understood the plan in advance are the ones who come back.
Free Online Botox® Training · Earn 1 CME Try Botox® training free.
Earn 1 CME on us.
Get self-paced access to a real IAPAM Botox® module — watch step-by-step injection technique, follow along with our physician instructors, and claim 1 AMA PRA Category 1 CME when you finish.
What’s Inside Your Free Module
Crow’s Feet Treatment TechniqueStep-by-step video
Facial Anatomy & Injection SitesHD video
Patient Consultation & SafetyBest practices
1 AMA PRA Cat 1 CMEOn completion
Full Module Value$79 — Free
Eligibility: MD/DO, NP, APRN/CRNA, PA, DMD/DDS, RN
Frequently Asked Questions
What is the on-label Botox® Cosmetic dose for glabellar lines?
The BOTOX® Cosmetic label specifies 4 Units into each of 5 sites for a total dose of 20 Units. Higher totals are used in practice, particularly in male patients with larger corrugator and procerus muscles, but anything above 20 Units for the glabellar complex is off-label and should be documented as such in your consent and chart.
What needle gauge should be used for Botox® injections?
The label instructs you to remove the needle used to reconstitute the product and attach a 30–33 gauge needle for injection. Many injectors work at the finer end of that range, using a 31 or 32 gauge insulin-style syringe, because a smaller bore reduces injection discomfort. Use a fresh, single-use needle for every patient.
How far from the orbital rim should glabellar injections be placed?
The label gives two separate margins that are often merged by mistake. Place lateral corrugator injections at least 1 cm above the bony supraorbital ridge, and do not inject closer than 1 cm above the central eyebrow. Respecting both is what keeps product away from the levator palpebrae superioris and reduces the risk of eyelid ptosis.
How long can reconstituted Botox® Cosmetic be kept?
Administer reconstituted BOTOX® Cosmetic within 24 hours. During that window store the reconstituted vial in a refrigerator at 2–8 °C. Reconstitute with preservative-free 0.9% sodium chloride injection only, and record the reconstitution date and time on the vial.
Can Units of Botox® be converted to Units of Dysport® or Xeomin®?
No. The label is explicit that Units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into Units of any other botulinum toxin product. Each product has its own potency assay, its own dilution instructions and its own dosing. This is the reason to verify the product identity at preparation, at removal from storage and again immediately before injecting.
Should patients stop blood thinners before Botox® injections?
Patients may reasonably pause elective over-the-counter agents that increase bruising — aspirin taken for no medical indication, ibuprofen, vitamin E, fish oil, ginseng and ginkgo biloba — for about a week beforehand. Prescribed anticoagulant and antiplatelet therapy is different: never instruct a patient to stop a prescribed blood thinner. That decision belongs to the prescribing physician, and the bruising risk is far smaller than the thrombotic risk of stopping.
Is masseter Botox® FDA approved?
Not yet. Masseter injection for jawline slimming is currently an off-label use in the United States. Allergan Aesthetics announced on 4 August 2026 that the FDA had accepted a supplemental Biologics License Application for BOTOX® Cosmetic in masseter muscle prominence, which would be its fifth aesthetic indication. Until an approval is issued, treat and document masseter treatment as off-label.
Build the Technique Before You Build the Practice
Every tip on this list comes back to the same thing: confident injecting is knowing the labeled numbers cold, knowing exactly where you are departing from them and why, and having said all of it out loud to the patient before you start. Anatomy and dosing you can study. Judgement, hand position and the feel of a corrugator under a 32 gauge needle you have to build on real faces, with someone experienced standing next to you.
That is what the IAPAM’s hands-on Botox® training is for — four days in a working Scottsdale clinic, live models, board-certified instructors, and AMA PRA Category 1 CME. Twenty years, 15,000-plus providers trained, and 4.9 out of 5 across more than 6,300 reviews.
20Years training providers
15,000+Providers trained
4.9/5From 6,300+ reviews
33.5CMEs, 4-day hands-on
Explore Hands-On Botox® Training → Start With a Free CME Module →
Questions about which training path fits your license and your schedule? Talk to a program advisor at 800-485-5759.
Disclaimer: This guide is for informational and educational purposes only and does not constitute medical advice. Treatment plans, injection techniques, and dosing must be tailored to each patient by a qualified, licensed provider. Always follow product labeling, your scope of practice, and your state medical and nursing board regulations. Botox® is a registered trademark of Allergan, Inc., an AbbVie company; Dysport® is a registered trademark of Ipsen; Xeomin® is a registered trademark of Merz Aesthetics; Jeuveau® is a registered trademark of Evolus; Daxxify® is a registered trademark of Revance Therapeutics; Letybo® is a registered trademark of Hugel.
